← Open Payments lookup

MATTHEW CULBRETH: Open Payments

NPI 1790352722 · JEFFERSONVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,082 in 91 payments from 14 companies in 2025. Trend: 2023 $1,370 · 2024 $1,522 · 2025 $2,082

Food & beverage: $1,891Education: $191
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.22$582
Alkermes, Inc.16$505
Otsuka America Pharmaceutical, Inc.16$258
ABBVIE INC.11$167
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$159
E.R. Squibb & Sons, L.L.C.3$82
Janssen Pharmaceuticals, Inc2$60
Indivior Inc.2$48
Neurocrine BioSciences, Inc.2$47
Vanda Pharmaceuticals Inc.2$46

Products named: ARISTADA, UZEDY, VRAYLAR, CAPLYTA, REXULTI, LYBALVI, ABILIFY ASIMTUFII, COBENFY.

Industry payments across IN — which companies pay providers there.